Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5276 USD | -5.07% | +1.01% | -2.89% |
Mar. 22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
Mar. 14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.89% | 115M | |
+9.22% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.47% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.95% | 16.96B | |
+7.58% | 14.16B | |
+40.03% | 12.63B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Transcript : Sangamo Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024